Blog Clinic Patient-Centered Specialization 
Aspiring Minority Doctor
DECEMBER 17, 2023
Okay, now I'll admit I've done a horrible job of keeping up with the blog lately especially given that this is only my fifth post of the year, but today is still super special for me. This blog has helped a lot with some of my successes. When I started this blog she had just turned 7, and now my baby is 17!
FDA Law
JULY 17, 2024
Peter Marks at James Valentine ’s FDA Rare Disease Town Hall session at the DIA Annual Meeting last month (see Pink Sheet coverage here ), this Hub is intended to serve as the Center of Excellence that we in the rare disease community have been calling for its establishment over the last several years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law
OCTOBER 16, 2023
Gonzalez — The Wall Street Journal (WSJ) recently published a series of articles as part of its special report “What’s Ahead for Artificial Intelligence.” Just a day earlier, FDA’s Center for Devices and Radiological Health (CDRH) released a list of the guidance documents the Center intends to publish in the upcoming 2024 fiscal year.
Barton Associates
MAY 8, 2025
In this blog, we’re going to outline four key ways temporary medical staff such as locum tenens providers can help healthcare facilities maintain continuity of high-quality patient care in the face of growing shortages. These professionals play a vital role in maintaining essential services and ensuring continuity of patient care.
Vascular Physician
OCTOBER 26, 2021
What is Hyperbaric Oxygen Therapy and How it Helps Heal Wounds Hyperbaric oxygen (HBO) therapy involves treating patients with 100% oxygen (O2) at elevated atmospheric pressures in a specially designed chamber. Most patients lie on their backs or sit up just slightly.
FDA Law
NOVEMBER 6, 2024
Starting in 2022 with a patent certification requirement, both Jazz and Avadel have sued FDA over this drug, with Jazz most recently bringing suit challenging FDA’s decision that Avadel’s Lumryz (sodium oxybate) is clinically superior to Jazz’s Xywav (sodium oxybate) in 2023. The Court held that it does.
FDA Law
JUNE 23, 2021
Valentine — For the last 13 years, this blogger has been at the center of what has now been dubbed “patient-focused drug development.” For 6 years, I served as a patient liaison within FDA in what was then called the Office of Special Health Issues. By James E. The practice of medicine was viewed as paternalistic.
Expert insights. Personalized for you.
52 
Let's personalize your content